Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Archives of Dermatology
doi 10.1001/archdermatol.2010.142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

JAMA Dermatology
DermatologyMedicine
2013English

Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome

2020English

Tumor Necrosis Factor

2004English

Successful Treatment of Refractory Behçet’s Myositis With Tumor Necrosis Factor Inhibitor

Hong Kong Bulletin on Rheumatic Diseases
2018English

Chronic Recurrent Multifocal Osteomyelitis: Treatment With a Tumor Necrosis Factor-Alpha Inhibitor

Turkish Journal of Rheumatology
2013English

A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-Associated Factor Domains

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases
Rheumatology
2016English

Tumor Necrosis Factor (TNF) Receptor 1 Signaling Downstream of TNF Receptor-Associated Factor 2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy